The Cardiopulmonary Effects of Calcitonin-Gene Related Peptide Family Kalsitonin-Geni İle İlişkili Peptit Ailesinin Kardiyopulmoner Etkileri


Creative Commons License

TELLİ G., TEL B. C. , GÜMÜŞEL B.

Turkish Journal of Pharmaceutical s, vol.17, pp.349-356, 2020 (ESCI) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 17
  • Publication Date: 2020
  • Doi Number: 10.4274/tjps.galenos.2019.47123
  • Journal Name: Turkish Journal of Pharmaceutical s
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, EMBASE, International Pharmaceutical Abstracts, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.349-356
  • Keywords: CGRP family, cardiopulmonary diseases, adrenomedullin, adrenomedullin2, intermedin, pulmonary hypertension, VASCULAR SMOOTH-MUSCLE, PULMONARY ARTERIAL-HYPERTENSION, ACTIVITY-MODIFYING PROTEINS, INCREASED PLASMA-LEVELS, CENTRAL-NERVOUS-SYSTEM, NITRIC-OXIDE, REGIONAL HEMODYNAMICS, SIGNAL-TRANSDUCTION, ENDOTHELIAL-CELLS, DEPENDENT PATHWAY
  • Hacettepe University Affiliated: Yes

Abstract

Cardiopulmonary diseases are very common among the population. They are high -cost diseases and there are still no definitive treatments. The roles of members of the calcitonin-gene related -peptide (CGRP) family in treating cardiopulmonary diseases have been studied for many years and promising results obtained. Especially in recent years, two important members of the family, adrenomedullin and adrenomedullin2/intermedin, have been considered new treatment targets in cardiopulmonary diseases. In this review, the roles of CGRP family members in cardiopulmonary diseases are investigated based on the studies performed to date.